<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oral Health</journal-id>
<journal-title>Frontiers in Oral Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oral Health</abbrev-journal-title>
<issn pub-type="epub">2673-4842</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/froh.2025.1615280</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oral Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Construction of an HBPL antibacterial coating on a phase-transition lysozyme-modified titanium surface</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Zhangyi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Xiangyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3041042/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/></contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Hengyang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Shuai</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Liang</surname><given-names>Hong</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>School and Hospital of Stomatology, Tianjin Medical University</institution>, <addr-line>Tianjin</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Stomatology, Tianjin Fifth Central Hospital</institution>, <addr-line>Tianjin</addr-line>, <country>China</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Department of Stomatology, Ecological City Hospital of Tianjin Fifth Central Hospital</institution>, <addr-line>Tianjin</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Seref Akay, University of Copenhagen, Denmark</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Xiaofei Dong, Zhejiang University, China</p>
<p>Aslihan Kazan, Bursa Technical University, T&#x00FC;rkiye</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Xiangyu Zhang <email>xzhang04@tmu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>27</day><month>06</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>6</volume><elocation-id>1615280</elocation-id>
<history>
<date date-type="received"><day>21</day><month>04</month><year>2025</year></date>
<date date-type="accepted"><day>16</day><month>06</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Li, Zhang, Yu, Zhang and Liang.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Li, Zhang, Yu, Zhang and Liang</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>In the field of dental implantation, titanium and its alloys serve as primary materials for implants due to their excellent biocompatibility. However, their insufficient antibacterial properties remain a critical limitation. Bacterial adhesion and subsequent biofilm formation on titanium alloy implant surfaces can trigger peri-implant inflammation, potentially leading to severe complications such as implant failure. To address this challenge, we developed a novel surface modification strategy that endows implants with dual functionality of antibacterial activity and enhanced cellular adhesion, thereby proposing a new approach for preventing and managing peri-implantitis.</p>
</sec><sec><title>Methods</title>
<p>A layer-by-layer (LbL) self-assembly technique was employed to construct polyelectrolyte coatings composed of hyperbranched polylysine (HBPL) and hyaluronic acid (HA) on phase-transitioned lysozyme (PTL)-modified titanium surfaces. The surface characteristics were systematically investigated through scanning electron microscopy (SEM) and energy-dispersive x-ray spectroscopy (EDS). Antibacterial efficacy was evaluated by monitoring bacterial viability and morphological alterations. Cytocompatibility assessments and molecular biological investigations were conducted to examine cellular responses and osteogenesis-related gene expression.</p>
</sec><sec><title>Results</title>
<p>A novel polyelectrolyte coating with favorable biocompatibility and antibacterial properties was successfully fabricated on PTL-modified titanium surfaces. This coating demonstrated significant antimicrobial effects while concurrently promoting osteogenic differentiation to a certain extent.</p>
</sec><sec><title>Conclusion</title>
<p>This study presents a dual-functional implant surface coating with combined antibacterial and osteogenic-enhancing capabilities. The developed strategy provides new insights for clinical surface modification of dental implants and offers a promising solution for peri-implantitis prevention and treatment.</p>
</sec>
</abstract>
<kwd-group>
<kwd>implant</kwd>
<kwd>surface modified</kwd>
<kwd>phase-transited lysozyme</kwd>
<kwd>chitosan</kwd>
<kwd>hyaluronic acid</kwd>
<kwd>hyperbranched poly-L-lysine</kwd>
</kwd-group><contract-num rid="cn001">TJWJ2023MS052</contract-num><contract-sponsor id="cn001">Tianjin Municipality Health Science and Technology Project</contract-sponsor><counts>
<fig-count count="8"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="32"/><page-count count="16"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Oral Infections and Microbes</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Dental implants are clinically utilized for restoring defective dentition caused by pathological conditions or traumatic injuries, serving as artificial tooth roots. Owing to their excellent biocompatibility and physicochemical properties, titanium and its alloys have gained extensive applications in maxillofacial surgery and the field of dental implantation (<xref ref-type="bibr" rid="B1">1</xref>). Although the majority of patients demonstrate favorable postoperative recovery, clinical evidence indicates that approximately 10&#x0025; of implants fail to function properly or even experience failure post-implantation, ultimately resulting in compromized surgical outcomes (<xref ref-type="bibr" rid="B2">2</xref>). Clinical studies reveal that approximately 18&#x0025; of implant cases exhibit aseptic loosening, while bacterial infection-induced inflammatory complications&#x2014;peri-implantitis and peri-implant mucositis&#x2014;are observed in as high as 20&#x0025; of cases (<xref ref-type="bibr" rid="B3">3</xref>). This phenomenon primarily stems from the disruption of the delicate microbial equilibrium within the oral cavity following implant placement, thereby predisposing the site to bacterial colonization-associated infections and elevating the risk of implant failure. Such complications not only compromise patients&#x0027; quality of daily life but may ultimately lead to implant loosening or failure, imposing substantial financial burdens and psychological distress on affected individuals (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>To address the insufficient antimicrobial efficacy of titanium implants, researchers have directed their efforts toward the rational design and implementation of surface modification technologies, with the dual objectives of enhancing surface-specific antibacterial properties while maintaining intrinsic biocompatibility. Inspired by natural amyloid proteins, pioneering studies have demonstrated the strategic denaturation of functionally tailored proteins [e.g., lactoferrin (<xref ref-type="bibr" rid="B5">5</xref>), lysozyme (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), silk fibroin (<xref ref-type="bibr" rid="B8">8</xref>), and bovine serum albumin (<xref ref-type="bibr" rid="B9">9</xref>)] to achieve surface adhesion on biomaterials. This denaturation-mediated approach serves dual purposes as both a foundational platform for subsequent surface modifications and a novel bioadhesive strategy for dental implant interfaces. The layer-by-layer (LbL) technique, functioning as an eco-friendly drug delivery system with facile fabrication, operates via electrostatic attraction between oppositely charged polyelectrolytes (<xref ref-type="bibr" rid="B10">10</xref>). This cyclic deposition process enables the formation of hierarchically ordered multilayered films through precisely controlled self-assembly mechanisms. The construction of a primarily functionalized interface constitutes the cornerstone for both enabling antibacterial efficacy in biomaterials and ensuring robust immobilization of antimicrobial coatings onto implant surfaces.</p>
<p>This study employed a novel amyloid-like assembly modification material&#x2014;phase-transitioned lysozyme (PTL) functional coating&#x2014;characterized by cost-effectiveness, wide availability, structural robustness, and environmental benignity. This innovative approach holds critical significance for primary functional interface modification on material surfaces, providing an effective strategy to synergistically enhance the antibacterial performance and biocompatibility of implant materials.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<sec id="s2a"><label>2.1</label><title>Preparation of smooth titanium sheet</title>
<p>Circular titanium discs with diameters of 4, 8, 15, and 20&#x2005;mm and thicknesses of 1 and 2&#x2005;mm were mechanically ground and polished using silicon carbide sandpaper (grit size: 800&#x2013;2,000). Subsequently, the samples underwent sequential ultrasonic cleaning in acetone, absolute ethanol, and deionized water for 15&#x2005;min per solvent. After drying at 60&#x00B0;C for 1&#x2005;h in a vacuum oven, all specimens were sterilized via autoclaving at 121&#x00B0;C under 15&#x2005;psi pressure for 20&#x2005;min.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Surface phase transformation lysozyme modification of pure titanium</title>
<p>Lysozyme and TCEP solution were mixed at a 1:1 molar ratio and applied dropwise onto titanium disc surfaces, followed by gentle agitation for homogeneous distribution (<xref ref-type="bibr" rid="B11">11</xref>). To mitigate solvent evaporation during incubation, the samples were placed in a humidified chamber containing deionized water and maintained at room temperature for 2&#x2005;h. Subsequently, the substrates were thoroughly rinsed with HEPES buffer (10&#x2005;mM, pH 7.4), air-dried under laminar flow, and stored in sterile Petri dishes at 4&#x00B0;C. These functionally modified specimens were designated as Ti-PTL (<xref ref-type="fig" rid="F1">Figure&#x00A0;1c</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p><bold>(a)</bold> Zeta potential values of two polyelectrolytes. <bold>(b)</bold> Congo red staining of titanium discs modified with phase-transitioned lysozyme (PTL). <bold>(c)</bold> Schematic illustration of layer-by-layer (LbL) assembly process for HA/HBPL coating fabrication on PTL-modified titanium. <bold>(d)</bold> Macroscopic photographs of titanium substrates after sequential surface modifications. <bold>(e)</bold> Field-emission scanning electron microscopy (FE-SEM) images of modified specimens post self-assembly.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g001.tif"><alt-text content-type="machine-generated">Graph (a) shows the zeta potential of HA and HBPL, with HBPL having a positive value and HA negative. Image (b) displays the pre-stained and Congo red-stained PTL samples. Diagram (c) outlines the preparation steps of Ti, Ti-PTL, and multilayered Ti-[HA/HB] coatings using lysozyme and TCEP. Image (d) shows five circular samples: Ti, PTL, HA, HA/HBPL, and HA/HBPL&#x2083;. Micrographs in (e) provide detailed views of Ti, PTL, HA, and HA/HBPL surfaces, highlighting differences in texture and structure.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2c"><label>2.3</label><title>Construction of Layer-by-Layer (LbL) self-assembled polyelectrolyte coatings was performed on modified titanium surfaces</title>
<p>The Ti-PTL samples were immersed in a hyaluronic acid (HA) solution (1&#x2005;mg/ml) for 30&#x2005;min, followed by thorough rinsing with 0.14&#x2005;M sodium chloride (NaCl) solution. After drying under nitrogen flow, the treated substrates were incubated in a hyperbranched polylysine (HBPL) solution (3&#x2005;mg/ml) for 30&#x2005;min to form a positively charged polyelectrolyte film, completing one coating assembly cycle (<xref ref-type="bibr" rid="B12">12</xref>). The resultant specimens were designated as Ti-PTL-HA/HBPL (abbreviated HA/HB). This cycle was repeated three times to construct multilayered polyelectrolyte composite coatings (<xref ref-type="fig" rid="F1">Figure&#x00A0;1c</xref>), with the final samples labeled Ti-PTL-[HA/HBPL]<sub>3</sub> [abbreviated (HA/HB)<sub>3</sub>].</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Characterization and analysis of titanium substrates with modified polyelectrolyte coatings</title>
<p>Zeta potential measurements of the nanoparticle suspensions were conducted using a Malvern Zetasizer Nano ZS instrument (Malvern Instruments, UK). The prepared electrolyte solutions were adjusted to pH 7.0, and 1&#x2005;ml aliquots were loaded into disposable zeta potential cuvettes. Measurements were performed at a scattering angle of 173&#x00B0; (backscatter detection mode) with strict temperature control maintained at 25.0&#x2009;&#x00B1;&#x2009;0.1&#x00B0;C using a Peltier thermal regulation system.</p>
<p>Congo red dye, known for its specific binding affinity toward amyloid-like structures, was employed to evaluate protein conformational changes. Titanium specimens were immersed in 1&#x2005;mg/ml Congo red solution (Sigma-Aldrich) for 10&#x2005;h under dark conditions. Following incubation, samples were meticulously rinsed with sterile deionized water for 10&#x2005;h using a peristaltic washing system (50&#x2005;ml/min flow rate), air-dried in a Class 100 clean bench, and visually inspected for structural coloration.</p>
<p>x-ray photoelectron spectroscopy (XPS, Shimadzu AXIS Supra&#x002B;, Japan) equipped with a monochromatic Al K&#x03B1; x-ray source (1,486.6&#x2005;eV, 15&#x2005;mA emission current) was utilized to analyze the near-surface chemical composition. All spectra were charge-corrected using adventitious carbon (C 1s&#x2009;&#x003D;&#x2009;284.8&#x2005;eV) as an internal reference. Critical point drying (Leica EM CPD300) was performed prior to sputter-coating samples with a 5&#x2005;nm gold layer (Quorum Q150T ES, 35&#x2005;s coating time) to enhance surface conductivity.</p>
<p>Field emission scanning electron microscopy (FE-SEM, ZEISS Sigma 500, Germany) coupled with energy-dispersive x-ray spectroscopy (EDS, Oxford X-MaxN 80) was employed for topographical imaging and elemental mapping at 5&#x2005;kV accelerating voltage. Atomic force microscopy (AFM, Bruker Dimension Icon, Germany) operated in PeakForce Tapping&#x2122; mode (ScanAsyst-Air probes, 0.7&#x2005;N/m spring constant) provided nanoscale roughness quantification and coating thickness measurements through cross-sectional analysis (<italic>n</italic>&#x2009;&#x003D;&#x2009;9 scans per sample).</p>
</sec>
<sec id="s2e"><label>2.5</label><title>Contact angle analysis</title>
<p>The hydrophilic properties of modified titanium substrates were evaluated using a dynamic contact angle measurement system (OCA25, Xiamen Chongda Technology Co., Ltd., China) under ambient conditions (25&#x2009;&#x00B1;&#x2009;0.5&#x00B0;C). Deionized water droplets (3&#x2005;&#x03BC;l) were dispensed onto specimen surfaces via a precision microsyringe. Following droplet stabilization (30&#x2005;s equilibration time), baseline calibration and contact angle measurements were performed using sessile drop methodology. Three distinct locations were selected per sample for triplicate measurements, with mean contact angles calculated to &#x00B1;0.1&#x00B0; precision. High-resolution droplet profiles were captured in real-time using integrated optical imaging (1,920&#x2009;&#x00D7;&#x2009;1,080 pixel resolution) and analyzed via dedicated image analysis software (Attension Theta v5.0) to quantify wettability parameters, with all raw data archived for precise angle quantification.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Drug release profiling</title>
<p>The drug release kinetics of experimental specimens [Ti-PTL-(HA/HBPL)<sub>3</sub> and Ti-PTL-HA/HBPL] were evaluated using a standardized elution protocol. Samples were immersed in phosphate-buffered saline (PBS, pH 7.4) within 24-well plates and incubated under gentle agitation (50&#x2005;rpm) in a thermostatic orbital shaker (37&#x2009;&#x00B1;&#x2009;0.2&#x00B0;C). At predetermined intervals (6&#x2005;h, 12&#x2005;h, 1&#x2005;d, 3&#x2005;d, 7&#x2005;d, 10&#x2005;d, and 14&#x2005;d), 200&#x2005;&#x03BC;l aliquots were extracted for quantitative analysis via bicinchoninic acid (BCA) protein assay (Pierce&#x2122;, Thermo Scientific), with absorbance measured at 562&#x2005;nm using an M200 Pro microplate reader (Tecan Group Ltd., Switzerland). The release medium was replenished with fresh PBS after each sampling to maintain sink conditions. Cumulative protein release was calculated against a six-point calibration curve (R<sup>2</sup>&#x2009;&#x003E;&#x2009;0.995) and plotted as mean&#x2009;&#x00B1;&#x2009;SD (<italic>n</italic>&#x2009;&#x003D;&#x2009;3 independent replicates).</p>
</sec>
<sec id="s2g"><label>2.7</label><title>Agar diffusion antibacterial assay</title>
<p>Test specimens [Ti, PTL, HA/HBPL, and (HA/HBPL)<sub>3</sub>] were precision-cut into discs (10&#x2005;mm diameter) using laser ablation, sequentially sterilized in absolute ethanol, sonicated in deionized water for 10&#x2005;min, and vacuum-dried at 80&#x00B0;C for 2&#x2005;h prior to autoclave sterilization. <italic>Streptococcus gordonii</italic> and <italic>S. sanguinis</italic> were cultured in brain-heart infusion (BHI) broth at 37&#x00B0;C under microaerophilic conditions (5&#x0025; CO<sub>2</sub>) for 18&#x2005;h to mid-log phase. Bacterial suspensions were adjusted to 1&#x2009;&#x00D7;&#x2009;10<sup>6</sup>&#x2005;CFU/ml using sterile saline (0.9&#x0025; NaCl) with optical density calibration at 600&#x2005;nm (OD<sub>600</sub>&#x2009;&#x003D;&#x2009;0.1). Sterile cotton swabs were used to evenly inoculate Mueller-Hinton agar plates with 100&#x2005;&#x03BC;l bacterial suspension. Specimens were aseptically placed onto inoculated agar surfaces, ensuring full material-agar contact via sterile forceps. Plates were incubated at 37&#x00B0;C for 48&#x2005;h under controlled humidity. Post-incubation, inhibition zones were documented using a calibrated imaging system under uniform LED illumination. Colony counting was performed using automated image analysis software (ImageJ v1.53t) with morphological filtering to differentiate inhibition halos from background colonies.</p>
</sec>
<sec id="s2h"><label>2.8</label><title>Live/dead bacterial viability assay via confocal laser scanning microscopy</title>
<p>Sterilized specimens were aseptically transferred into 24-well cell culture plates and inoculated with 1&#x2005;ml of bacterial suspension. Following 24&#x2005;h incubation at 37&#x00B0;C under 5&#x0025; CO<sub>2</sub>, the culture medium was aspirated, and specimens underwent three PBS washing cycles with gentle orbital shaking. A fluorescent viability stain cocktail was prepared by mixing SYTO 9 and propidium iodide (PI) at a 1:1 volumetric ratio. Each well received 200&#x2005;&#x03BC;l of staining solution and was incubated protected from light at ambient temperature for 15&#x2005;min. Excess dye was removed through three additional PBS rinses under dark conditions.Samples were immediately imaged using a confocal laser scanning microscope. Fluorescence quantification was executed via ZEN 3.4 software, with live bacteria (SYTO 9) and dead bacteria (PI) populations calculated from thresholded binarized images (<xref ref-type="bibr" rid="B13">13</xref>).</p>
</sec>
<sec id="s2i"><label>2.9</label><title>Scanning electron microscopy analysis of bacterial morphology</title>
<p>The four experimental materials were individually placed in 24-well culture plates and inoculated with 1&#x2005;ml suspensions of <italic>Streptococcus gordonii</italic> and <italic>S. sanguinis</italic> at a 1:1 ratio (1&#x2009;&#x00D7;&#x2009;10<sup>6</sup>&#x2005;CFU/ml total). Biofilms were cultivated microaerophilically (37&#x00B0;C, 5&#x0025; CO<sub>2</sub>) for 24&#x2005;h. Specimens were gently rinsed thrice with PBS under orbital agitation and fixed in 2.5&#x0025; glutaraldehyde at 4&#x00B0;C for 4&#x2005;h. A graded ethanol dehydration series (50&#x0025;, 70&#x0025;, 80&#x0025;, 90&#x0025;, 100&#x0025; v/v, 15&#x2005;min per step) was performed using an automated tissue processor. Critical point drying preceded sputter-coating with 5&#x2005;nm gold-palladium (Quorum Q150T ES, 30&#x2005;mA, 120&#x2005;s) to enhance surface conductivity. High-resolution imaging was conducted via field-emission scanning electron microscopy at 5&#x2005;kV accelerating voltage (<xref ref-type="bibr" rid="B14">14</xref>). Bacterial adhesion density, morphological alterations, and spatial distribution patterns were quantified across 10 random fields using SmartSEM v6.0 image analysis suite, with biofilm coverage calculated via threshold-based binarization.</p>
</sec>
<sec id="s2j"><label>2.10</label><title>Cell culture</title>
<p>Murine pre-osteoblastic MC3T3-E1 cells were cultured in high-glucose Dulbecco&#x0027;s Modified Eagle Medium (DMEM, Gibco) supplemented with 10&#x0025; fetal bovine serum (FBS, HyClone) and 1&#x0025; penicillin/streptomycin (P/S, Sigma-Aldrich) under standard conditions (37&#x00B0;C, 5&#x0025; CO<sub>2</sub>, 100&#x0025; humidity). Rat bone marrow-derived mesenchymal stem cells (BMSCs) were maintained in DMEM/F-12 medium (Corning) containing 10&#x0025; FBS and 1&#x0025; P/S within a humidified tri-gas incubator (Thermo Scientific Forma Series II) with identical atmospheric parameters.</p>
</sec>
<sec id="s2k"><label>2.11</label><title>Lactate dehydrogenase (LDH) cytotoxicity assay on titanium substrates</title>
<p>Confluent MC3T3-E1 cells were trypsinized (0.25&#x0025; Trypsin-EDTA), centrifuged (300 &#x00D7;g, 5&#x2005;min), and resuspended in complete medium to achieve 4&#x2009;&#x00D7;&#x2009;10<sup>4</sup>&#x2005;cells/ml. Sterilized titanium specimens (<italic>n</italic>&#x2009;&#x003D;&#x2009;3 technical replicates per group) were aseptically placed in 24-well plates, followed by addition of 1&#x2005;ml cell suspension per well. Cells were cultured under standard conditions (37&#x00B0;C, 5&#x0025; CO<sub>2</sub>, 95&#x0025; humidity) for 24&#x2005;h.Post-incubation, cells were lysed using RIPA buffersupplemented with protease inhibitors. Lysates were sonicated on ice and centrifuged to obtain clarified supernatants. LDH activity was quantified using the CytoTox 96&#x00AE; Non-Radioactive Cytotoxicity Assay (Promega) according to manufacturer protocols (<xref ref-type="bibr" rid="B15">15</xref>). Absorbance at 490&#x2005;nm was measured with correction at 650&#x2005;nm using a multimode plate reader.</p>
</sec>
<sec id="s2l"><label>2.12</label><title>CCK-8 assay for cellular proliferation on titanium substrates</title>
<p>Cellular proliferation kinetics were assessed daily (Days 1&#x2013;6) by supplementing cultures with 10&#x0025; CCK-8 reagent (Dojindo Molecular Technologies) relative to total medium volume. Following 4&#x2005;h incubation under standard conditions (37&#x00B0;C, 5&#x0025; CO<sub>2</sub>, 95&#x0025; humidity), absorbance was quantified at 450&#x2005;nm (reference wavelength: 650&#x2005;nm) using a multimode microplate reader. Triplicate technical replicates per group were analyzed at each timepoint, with background subtraction using cell-free control wells.</p>
</sec>
<sec id="s2m"><label>2.13</label><title>Alkaline phosphatase activity assay</title>
<p>ALP activity was determined using a microplate-based Alkaline Phosphatase Assay Kit according to the manufacturer&#x0027;s instructions. The optical density was measured at 405&#x2005;nm using a microplate reader.</p>
</sec>
<sec id="s2n"><label>2.14</label><title>Protein adsorption quantification assay</title>
<p>Surface-modified titanium specimens (<italic>n</italic>&#x2009;&#x003D;&#x2009;3 technical replicates per group) were aseptically transferred into 24-well plates and incubated with 1&#x2005;ml DMEM medium supplemented with 10&#x0025; fetal bovine serum (FBS, HyClone) under standardized culture conditions for 4&#x2005;h. Following incubation, specimens were gently transferred to fresh plates using sterile forceps and subjected to three PBS washing cycles with orbital shaking (50&#x2005;rpm, 5&#x2005;min/wash). Adsorbed proteins were desorbed using 0.5&#x2005;ml of 1&#x0025; sodium dodecyl sulfate (SDS, Sigma-Aldrich) solution under constant agitation (200&#x2005;rpm) at 25&#x2009;&#x00B1;&#x2009;0.5&#x00B0;C for 1&#x2005;h. Protein concentrations were determined via Pierce&#x2122; BCA Protein Assay Kit (Thermo Scientific) following manufacturer protocols, with absorbance measured at 562&#x2005;nm using a SpectraMax i3x microplate reader.</p>
</sec>
<sec id="s2o"><label>2.15</label><title>Alizarin red S staining for mineralized matrix deposition</title>
<p>Cells were fixed with 4&#x0025; paraformaldehyde (PFA) in PBS (pH 7.4) for 15&#x2005;min at 25&#x00B0;C. After aspirating the fixative, specimens were triple-rinsed with deionized water. A 0.2&#x0025; Alizarin Red S (ARS) solution (Sigma-Aldrich, pH 8.3 adjusted with 0.1&#x2005;M Tris-HCl) was slowly applied to cover cell layers, followed by incubation in dark conditions for 30&#x2005;min. Excess dye was removed via brief rinsing (3&#x2009;&#x00D7;&#x2009;10&#x2005;s) with deionized water to prevent calcium mineral dissolution. Stained specimens were imaged under phase-contrast microscopy with consistent illumination parameters.</p>
</sec>
<sec id="s2p"><label>2.16</label><title>RT-qPCR</title>
<p>Total cellular RNA was extracted using chloroform-based phase separation, followed by reverse transcription into complementary DNA (cDNA) using the PrimeScript&#x2122; RT Reagent Kit according to the manufacturer&#x0027;s protocol. Quantitative real-time PCR amplification of target genes and endogenous controls was performed with SYBR&#x2122; Premix Ex Taq&#x2122; on a StepOnePlus&#x2122; Real-Time PCR System (Applied Biosystems). Primer sequences for the target and reference genes are listed below:
<list list-type="simple">
<list-item>
<p>OCN: F: TTGGCTTCTGACTGGGTGTC, R: GCCGGAGTCTGTTCACTACC;</p></list-item>
<list-item>
<p>OPN: F: GCAAACAAGAGGCCCATTTCA, R: GGACATCGACTGTAGGGACG;</p></list-item>
<list-item>
<p>RUNX2: F:GCCTCACTTAGCTAGGTCTCAG,R: AGGGAGGGCTGAACAATGTC;</p></list-item>
<list-item>
<p>COLI: F:ACATACAGCTTGTGAGGTCGC,R:CGTGACCACGGGCATAATTC;</p></list-item>
<list-item>
<p>GAPDH:F:GGGAGACAGCTCATGCATTTC,R:AATGACTATCCTTGTCCCAAGTCA.</p></list-item>
</list></p>
</sec>
<sec id="s2q"><label>2.17</label><title>Protein isolation and western blot analysis</title>
<p>Proteins were extracted in RIPA lysis buffer (CW2333s, CWBIO, Shanghai) supplemented with Phosphatase Inhibitor Cocktail (CW2200S, CWBIO, Shanghai) and Phenylmethylsulfonyl fluoride (PMSF) (Sigma). Then, centrifugation at 12,000&#x2005;rpm for 30&#x2005;min was performed to remove cell fragments. After centrifugation, protein concentrations of the supernatant were determined with the Bradford assay and the extract boiled in Laemmli buffer. After quantified, protein samples (10&#x2013;20&#x2005;&#x03BC;g) were separated by 10&#x0025; SDS&#x2013;PAGE for electrophoresis and then transferred to PVDF membranes. After blocking with 5&#x0025; skimmed milk for 1&#x2005;h, the membranes were incubated with indicated primary antibodies overnight at 4&#x00B0;C. Then, after washing with TBST for three times, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Weiao Biological Company, China) at room temperature for 1&#x2005;h. Protein bands were visualized using enhanced chemiluminescence (ECL) reagent (Cat:AP34L015-B, Life-iLab, Shanghai) with the Tanon 5,200 imaging system. The band intensities were analyzed by ImageJ (version 1.52a, NIH).</p>
</sec>
<sec id="s2r"><label>2.18</label><title><italic>In vivo</italic> foreign body implantation study</title>
<p>This investigation utilized 12-week-old male Sprague-Dawley rats (Beijing HFK Bioscience Co., Ltd.), with all procedures strictly adhering to the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals. The protocol was approved by the Animal Ethics Committee of Tianjin Fifth Central Hospital (AEWC-2023-018). Animals were housed in individually ventilated cages under controlled environmental conditions (25&#x00B0;C, 55&#x0025; humidity, 12&#x2005;h light/dark cycle) with <italic>ad libitum</italic> access to autoclaved water and feed.</p>
<p>Bone marrow-derived mesenchymal stem cells (BMSCs) were cultured on HA/HBPL<sub>3</sub> and bare titanium (Blank Ti) substrates for 7 days, with cellular morphology, distribution, and adhesion characterized via phase-contrast microscopy (Nikon Eclipse Ts2, 20&#x00D7;). Following intraperitoneal anesthesia (pentobarbital sodium, 50&#x2005;mg/kg), a 0.5&#x2005;cm longitudinal incision was aseptically created 2&#x2005;cm caudal to the auricular region. A subcutaneous pocket was surgically prepared using blunt dissection, into which pre-sterilized titanium specimens (<italic>n</italic>&#x2009;&#x003D;&#x2009;8 rats/group) were implanted. Wound closure was achieved with 5-0 polypropylene sutures, and postoperative analgesia (meloxicam, 1&#x2005;mg/kg) was administered for 72&#x2005;h.</p>
</sec>
<sec id="s2s"><label>2.19</label><title>Hematoxylin-eosin (H&#x0026;E) morphological staining</title>
<p>At 4 and 8 weeks post-implantation, dorsal tissue specimens containing titanium implants and surrounding tissues were harvested. Samples were fixed in 4&#x0025; neutral buffered formalin (Sigma-Aldrich) for 48&#x2005;h, followed by dehydration in graded ethanol series (70&#x0025; to 100&#x0025;), xylene clearing, and paraffin embedding (Leica EG1160). Serial sections (5&#x2005;&#x03BC;m thickness) were prepared using a rotary microtome (Leica RM2235).</p>
<p>Deparaffinization was performed through sequential immersion in xylene (3&#x2009;&#x00D7;&#x2009;5&#x2005;min) and rehydration via graded ethanol (100&#x0025; to 70&#x0025;). Tissue sections were stained using a commercial H&#x0026;E kit (Abcam, ab245880) according to manufacturer protocols: hematoxylin incubation (5&#x2005;min), differentiation in 1&#x0025; acid alcohol (30&#x2005;s), bluing in 0.2&#x0025; ammonium hydroxide (1&#x2005;min), and eosin counterstaining (2&#x2005;min). Stained slides were dehydrated (95&#x0025; and 100&#x0025; ethanol, 2&#x2005;min each), cleared in xylene, and mounted with neutral balsam (Sigma-Aldrich).</p>
<p>Histological evaluation was conducted under bright-field microscopy at 100&#x00D7; and 400&#x00D7; magnifications. Morphometric analysis of tissue integration and inflammatory response was performed using NIS-Elements BR 5.30 software, with semi-quantitative scoring based on ISO 10993-6:2016 criteria (8 animals/group).</p>
</sec>
<sec id="s2t"><label>2.20</label><title>Statistical analysis</title>
<p>Data collected from at least triplicate experiments are presented as means&#x2009;&#x00B1;&#x2009;standard deviation (SD) and analyzed with GraphPad Prism 9.0.0 via the one-way analysis of variance (ANOVA). The confidence levels were set as 95&#x0025; (<italic>p</italic>&#x002A;&#x2009;&#x003C;&#x2009;0.05), 99&#x0025; (<italic>p</italic>&#x002A;&#x002A;&#x2009;&#x003C;&#x2009;0.01), (<italic>p</italic>&#x002A;&#x002A;&#x002A;&#x2009;&#x003C;&#x2009;0.001) and (<italic>p</italic>&#x002A;&#x002A;&#x002A;&#x002A;&#x2009;&#x003C;&#x2009;0.0001).</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Surface modification of titanium and fabrication/characterization of hyperbranched polylysine (HBPL) self-assembled coatings</title>
<p>Zeta potential measurements revealed that HA exhibited a surface charge of &#x2212;52.47&#x2009;&#x00B1;&#x2009;1.02&#x2005;mV at pH 7, indicating strong negative charge density conducive to colloidal stability in aqueous solutions. Conversely, HBPL demonstrated a positive zeta potential of &#x002B;26.80&#x2009;&#x00B1;&#x2009;0.87&#x2005;mV, attributed to protonated amine groups within its dendritic architecture, which enhanced its dispersibility and interfacial stability (<xref ref-type="fig" rid="F1">Figure&#x00A0;1a</xref>). The complementary electrostatic profiles of HA and HBPL facilitated the formation of stable polyelectrolyte complexes via charge-driven self-assembly. Congo red staining, which selectively binds &#x03B2;-sheet-rich protein conformations, uniformly colored PTL-modified titanium surfaces (<xref ref-type="fig" rid="F1">Figure&#x00A0;1b</xref>), confirming the retention of amyloid-like structural motifs. Untreated titanium substrates displayed smooth, metallic surfaces with characteristic silver-gray luster. PTL functionalization introduced an opaque white proteinaceous layer, while subsequent HA treatment yielded a duller appearance with reduced reflectivity, indicative of surface charge modulation for electrostatic assembly. Sequential HBPL deposition and cyclic coating procedures produced darker hues without macroscopic morphological alterations, suggesting progressive optimization of coating thickness and homogeneity (<xref ref-type="fig" rid="F1">Figure&#x00A0;1d</xref>).</p>
<p>Scanning electron microscopy (SEM) elucidated the morphological evolution of titanium surfaces under distinct modification protocols (<xref ref-type="fig" rid="F1">Figure&#x00A0;1e</xref>). The Ti-PTL surface exhibited uniformly distributed globular nanostructures, while HA deposition yielded a smoother topography compared to pristine PTL-modified surfaces. Multilayered LbL-assembled coatings [Ti-PTL-(HA/HB)<sub>3</sub>] demonstrated enhanced surface homogeneity and reduced roughness relative to monolayer counterparts [Ti-PTL-(HA/HB)], indicative of progressive structural optimization.XPS survey spectra revealed elemental distribution profiles across modified surfaces (<xref ref-type="fig" rid="F2">Figures&#x00A0;2a,b</xref>), calibrated using the adventitious carbon C 1s peak (284.8&#x2005;eV). Untreated titanium displayed characteristic Ti 2p<sub>3</sub>/<sub>2</sub> (458.4&#x2005;eV) and O 1s (532&#x2005;eV) peaks. PTL-functionalized surfaces exhibited emergent S 2p (168.2&#x2005;eV) and P 2p (132.2&#x2005;eV) signatures originating from tris(2-carboxyethyl)phosphine (TCEP), concurrent with the disappearance of Ti 2p<sub>3</sub>/<sub>2</sub> signals, confirming complete surface coverage by phase-transitioned lysozyme. Subsequent HA deposition introduced a Na 1s peak (1,071&#x2005;eV), verifying successful anionic polymer immobilization. Layer-by-layer HBPL assembly generated a prominent N 1s peak (400&#x2005;eV), attributable to amine and amide functionalities, validating cationic polyelectrolyte incorporation. These results convincingly demonstrate the feasibility of constructing stable LbL architectures on titanium substrates, culminating in the successful fabrication of self-assembled Ti-[HA/HBPL]<sub>3</sub> antimicrobial coatings.</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p><bold>(a)</bold> EDS elemental mapping of specimens at different modification stages and after self-assembly. <bold>(b)</bold> XPS survey spectra of specimens at different modification stages and after self-assembly.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g002.tif"><alt-text content-type="machine-generated">Five panels labeled A to E show elemental mapping images and scanning electron microscopy of different coatings: Ti, PTL, HA, HA/HBPL, and HA/HBPL3, highlighting elements like titanium, carbon, oxygen, nitrogen, sodium, sulfur, and phosphorus. Another image shows x-ray photoelectron spectroscopy (XPS) spectra for these coatings, displaying peaks for various binding energies, indicating elemental composition and chemical states.</alt-text>
</graphic>
</fig>
<p>Atomic force microscopy (AFM) revealed distinct surface topographies across modified titanium groups (<xref ref-type="fig" rid="F3">Figure&#x00A0;3a</xref>). The Ti-PTL group exhibited significantly increased surface roughness compared to pristine titanium (Ra: 85.3&#x2009;&#x00B1;&#x2009;12.1&#x2005;nm vs. 22.4&#x2009;&#x00B1;&#x2009;3.5&#x2005;nm). Subsequent LbL assembly of HA and HBPL reduced surface roughness (Ra: 48.7&#x2009;&#x00B1;&#x2009;6.9&#x2005;nm), effectively masking the PTL underlayer. Progressive LbL cycles further optimized coating uniformity, culminating in a smooth, densely packed multilayer structure with a total thickness of 1.0&#x2009;&#x00B1;&#x2009;0.1&#x2005;&#x03BC;m (<xref ref-type="fig" rid="F3">Figure&#x00A0;3b</xref>). Water contact angle measurements demonstrated dynamic wettability evolution during coating fabrication (<xref ref-type="fig" rid="F3">Figure&#x00A0;3c</xref>). Untreated titanium exhibited inherent hydrophobicity (113.18&#x2009;&#x00B1;&#x2009;1.02&#x00B0;), while PTL functionalization dramatically enhanced hydrophilicity (13.97&#x2009;&#x00B1;&#x2009;3.80&#x00B0;), attributable to surface enrichment of polar groups (amino, hydroxyl, carboxyl) from denatured lysozyme. HA deposition moderately increased contact angles to 40.77&#x2009;&#x00B1;&#x2009;1.58&#x00B0;, likely due to steric reorganization of hydrophilic domains. Subsequent HBPL assembly stabilized wettability (39.6&#x2009;&#x00B1;&#x2009;3.32&#x00B0;), with terminal amine groups compensating for HA&#x0027;s spatial effects. Final LbL-optimized coatings [(HA/HBPL)<sub>3</sub>] maintained balanced hydrophilicity (54.00&#x2009;&#x00B1;&#x2009;0.44&#x00B0;), representing a 52&#x0025; improvement over untreated titanium.</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p><bold>(a)</bold> AFM images of different material surfaces. <bold>(b)</bold> AFM image showing the thickness of HA/HBPL<sub>3</sub> coating. <bold>(c)</bold> Water contact angles on various specimen surfaces. <bold>(d)</bold> Drug release profiles of polyelectrolyte-modified coatings. &#x002A;&#x002A;&#x002A;&#x002A;<italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g003.tif"><alt-text content-type="machine-generated">Group of images including:\n\n(a) Surface topography of Ti, PTL, HA/HBPL, and HA/HBPL&#x2083; substrates shown in both 2D and 3D atomic force microscopy (AFM) images displaying varied surface morphologies.\n\n(b) AFM images of Ti coated with PTL and a composite coating in 2D and 3D.\n\n(c) Bar chart and droplet images illustrating contact angles on different substrate surfaces, indicating significant differences in hydrophilicity.\n\n(d) Line graph showing cumulative release of HBPL over time for HA/HBPL and HA/HBPL&#x2083;, indicating trends in release percentages over 14 days.</alt-text>
</graphic>
</fig>
<p>Additionally, the cumulative release of HBPL from the modified titanium in PBS solution exhibited a time-dependent increase in both experimental groups, characterized by an initial rapid release phase followed by gradual attenuation (<xref ref-type="fig" rid="F3">Figure&#x00A0;3d</xref>).</p>
</sec>
<sec id="s3b"><label>3.2</label><title>Antibacterial properties of modified titanium surface</title>
<p>The agar diffusion assay revealed distinct bactericidal effects across experimental groups. Pure Ti substrates demonstrated the highest colonization density for both <italic>Streptococcus gordonii</italic> and <italic>S. sanguinis</italic>, with confluent biofilm formation nearly covering the entire agar surface (<xref ref-type="fig" rid="F4">Figures&#x00A0;4a,b</xref>). PTL-modified surfaces exhibited a moderate reduction in colony counts (approximately 30&#x0025; decrease vs. Ti), though bacterial distribution remained uniform. HA/HBPL coatings significantly suppressed <italic>S. gordonii</italic> growth (70&#x0025; reduction) while nearly eliminating <italic>S. sanguinis</italic> colonization (99&#x0025; inhibition). Remarkably, the HA/HBPL<sub>3</sub> group showed near-complete bactericidal efficacy (99.93&#x2009;&#x00B1;&#x2009;0.09&#x0025; inhibition), with only sporadic colonies observed.</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p><bold>(a)</bold> antibacterial performance of HA/HBPL<sub>3</sub> against <italic>Streptococcus gordonii</italic> and quantitative analysis results. <bold>(b)</bold> Antibacterial performance of HA/HBPL<sub>3</sub> against <italic>S. sanguinis</italic> and quantitative analysis results. <bold>(c)</bold> Confocal imaging comparisons of <italic>S. gordonii</italic> colonization patterns. <bold>(d)</bold> Confocal imaging comparisons of <italic>S. sanguinis</italic> colonization patterns. ns, <italic>P</italic>&#x2009;&#x003E;&#x2009;0.05; &#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.01; &#x002A;&#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001; &#x002A;&#x002A;&#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g004.tif"><alt-text content-type="machine-generated">Petri dishes and fluorescence microscopy images examining the antibacterial effects of different coatings on Streptococcus gordonii and S. sanguinis. (a) and (b) show bacterial colonies on different coatings with corresponding bar graphs indicating antibacterial rates. (c) and (d) display fluorescence images using SYTO 9 and propidium iodide on the bacteria under similar conditions, highlighting live and dead cells with a merge image. Each row and column represents variations in coatings, emphasizing differences in antibacterial effectiveness.</alt-text>
</graphic>
</fig>
<p>Live/dead fluorescence imaging corroborated these findings (<xref ref-type="fig" rid="F4">Figures&#x00A0;4c,d</xref>). Pure Ti surfaces displayed dense populations of viable bacteria. PTL modification reduced viable counts by 40&#x0025;, though bacterial vitality remained high. HA/HBPL surfaces exhibited membrane-compromised <italic>S. gordonii</italic> and near-complete eradication of <italic>S. sanguinis</italic>. The HA/HBPL<sub>3</sub> group demonstrated exceptional antimicrobial performance, with minimal viable bacteria detected (&#x003C;1&#x0025; survival).</p>
<p>High-resolution SEM imaging revealed mechanistic insights (<xref ref-type="fig" rid="F5">Figures&#x00A0;5a,b</xref>). Pure Ti surfaces hosted intact <italic>S. gordonii</italic> (red pseudocolor) with preserved cellular morphology and dense colonization. HA/HBPL surfaces showed reduced adhesion density and partial membrane disruption (white arrows). HA/HBPL<sub>3</sub> coatings induced catastrophic membrane damage (green arrows), characterized by cytoplasmic leakage and cell lysis. Similar trends were observed for <italic>S. sanguinis</italic> (green pseudocolor), with HA/HBPL<sub>3</sub> surfaces achieving complete membrane disintegration (white/red arrows).</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p><bold>(a)</bold> FE-SEM images of <italic>Streptococcus gordonii</italic>. <bold>(b)</bold> FE-SEM images of <italic>S. sanguinis</italic>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g005.tif"><alt-text content-type="machine-generated">Scanning electron microscope images of Streptococcus gordonii and S. sanguinis on different materials. Panel a shows red-stained S. gordonii on Ti, Ti-PTL, HA/HBPL, and HA/HBPL&#x2083; surfaces. Panel b shows green-stained S. sanguinis on Ti, Ti-PTL, HA/HBPL, and HA/HBPL&#x2083; surfaces. Arrows indicate specific features on surfaces. Scale bars represent 1 micrometer.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><label>3.3</label><title>Biocompatibility and <italic>in vivo</italic> heterotopic osteogenesis of modified titanium</title>
<p>The HA/HBPL<sub>3</sub> group demonstrated the lowest lactate dehydrogenase (LDH) activity, showing statistically significant differences compared to the Ti group. A sequential reduction in LDH activity was observed across Ti-PTL, Ti-PTL-HA, HA/HBPL, and HA/HBPL<sub>3</sub> groups. Notably, Ti-PTL and Ti-PTL-HA exhibited elevated LDH activity relative to pure Ti (<xref ref-type="fig" rid="F6">Figure&#x00A0;6a</xref>), suggesting transient metabolic stress during early-stage cell adaptation. These results confirm the minimal cytotoxicity of the composite coatings.</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p><bold>(a)</bold> LDH activity changes. <bold>(b)</bold> ALP activity changes. <bold>(c)</bold> BMSC proliferation assessment on differently treated titanium surfaces. <bold>(d)</bold> MC3T3-E1 proliferation assessment on differently treated titanium surfaces. <bold>(e)</bold> Protein adsorption quantification. ns: <italic>P</italic>&#x2009;&#x003E;&#x2009;0.05; &#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05; &#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.01; &#x002A;&#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001; &#x002A;&#x002A;&#x002A;&#x002A;: <italic>P</italic>&#x2009;&#x003C;&#x2009;0.0001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g006.tif"><alt-text content-type="machine-generated">Bar graphs comparing various treatments over time and their effects on cellular activity and protein absorption. Graph (a) shows LDH activity, graph (b) ALP value over 7 to 14 days, graph (c) OD value in BMSC from 1 to 7 days, graph (d) OD value in MC3T3-E1 from 1 to 7 days, and graph (e) absorbed protein. Statistical significance is indicated by asterisks. Each graph includes different treatments: Control, Ti, Ti-PTL, Ti-PTL-HA, HA/HBPL, and HA/HBPL&#x2083;, identified by color-coded bars.</alt-text>
</graphic>
</fig>
<p>To evaluate osteogenic differentiation, ALP activity was quantified at days 7 and 14. The HA/HBPL<sub>3</sub> group showed significantly enhanced ALP activity at both timepoints (2.3-fold increase vs. Ti at day 14), indicating sustained promotion of osteoblastic differentiation (<xref ref-type="fig" rid="F6">Figure&#x00A0;6b</xref>).</p>
<p>Proliferation kinetics of rat bone marrow-derived mesenchymal stem cells (BMSCs) and murine pre-osteoblastic MC3T3-E1 cells were assessed. For BMSCs, the HA/HBPL<sub>3</sub> group exhibited higher optical density (OD) values than Ti at day 3, with a slight reduction by day 7. Ti-PTL and Ti-PTL-HA showed no significant impact on BMSC proliferation (<xref ref-type="fig" rid="F6">Figure&#x00A0;6c</xref>). In contrast, HA/HBPL<sub>3</sub> significantly enhanced MC3T3-E1 proliferation at both days 3 and 7 compared to HA/HBPL and Ti-PTL-HA groups (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, <xref ref-type="fig" rid="F6">Figure&#x00A0;6d</xref>), demonstrating cell lineage-dependent bioactivity.</p>
<p>Protein adsorption capacity, indicative of surface bioactivity, was highest in the HA/HBPL<sub>3</sub> group (2.8&#x2009;&#x00B1;&#x2009;0.3&#x2005;&#x03BC;g/cm<sup>2</sup>), significantly exceeding Ti (1.1&#x2009;&#x00B1;&#x2009;0.2&#x2005;&#x03BC;g/cm<sup>2</sup>) and HA/HBPL (1.9&#x2009;&#x00B1;&#x2009;0.2&#x2005;&#x03BC;g/cm<sup>2</sup>). Ti-PTL-HA showed reduced adsorption (0.8&#x2009;&#x00B1;&#x2009;0.1&#x2005;&#x03BC;g/cm<sup>2</sup>) compared to Ti, while Ti-PTL exhibited comparable levels to Ti (1.0&#x2009;&#x00B1;&#x2009;0.2&#x2005;&#x03BC;g/cm<sup>2</sup>) (<xref ref-type="fig" rid="F6">Figure&#x00A0;6e</xref>).</p>
<p>Alizarin Red S staining demonstrated time-dependent mineralization capacity across groups (<xref ref-type="fig" rid="F7">Figures&#x00A0;7a&#x2013;c</xref>). The Ti group exhibited faint red staining, indicative of minimal calcium deposition. Gradual intensification of staining was observed in PTL, HA, and HA/HBPL groups, with the HA/HBPL<sub>3</sub> group showing the most robust red coloration at both 14 and 21 days. HA/HBPL<sub>3</sub> substrates displayed densely distributed, uniform mineralized nodules with 2.3-fold higher calcium content compared to Ti, confirming enhanced osteogenic mineralization.</p>
<fig id="F7" position="float"><label>Figure 7</label>
<caption><p><bold>(a)</bold> macroscopic view of alizarin Red S staining. <bold>(b)</bold> Microscopic observation of Alizarin Red S-stained specimens. <bold>(c)</bold> Quantitative analysis of Alizarin Red S staining intensity. <bold>(d)</bold> Cellular responses and morphological changes at 6&#x2005;h and 12&#x2005;h post-treatment.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g007.tif"><alt-text content-type="machine-generated">A composite scientific image showing four sections: (a) Petri dishes with Ti, PTL, HA, HA/HB, and HA/HB3 samples at 14 and 21 days, highlighting different coloration due to staining. (b) Microscopic images of the same sample types at 14 and 21 days, showing cellular structures. (c) Bar graph depicting OD values at 562 nm for each sample type at 14 and 21 days, indicating varying degrees of cellular activity. (d) Fluorescent images displaying phalloidin and DAPI staining with merged results for Ti, PTL, HA/HB, and HA/HB3 samples at 6 and 12&#x2005;h, illustrating cell morphology and nucleus visibility.</alt-text>
</graphic>
</fig>
<p>Phalloidin/DAPI staining revealed superior cellular integrity on HA/HBPL<sub>3</sub> surfaces (<xref ref-type="fig" rid="F7">Figure&#x00A0;7d</xref>). At 6 and 12&#x2005;h post-seeding, HA/HBPL<sub>3</sub>-supported cells exhibited well-defined actin filaments and organized nuclear architecture, with a 40&#x0025; increase in cell spreading area vs. Ti. In contrast, Ti, PTL, and HA/HBPL groups showed dispersed cytoskeletal networks and irregular nuclear arrangements, suggesting HA/HBPL<sub>3</sub>&#x0027;s protective effects on cellular homeostasis.</p>
<p>To evaluate the effects of different treatment conditions on bone metabolism-related genes, the expression levels of COL I, OPN, OCN, and RUNX2 genes were detected using RT-qPCR under different treatment conditions. The results showed that the HA/HBPL3 group exhibited better expression effects in all tested genes, significantly higher than the Ti group, particularly in the expression of OPN and RUNX2, which showed significant increases. This indicates that the HA/HBPL3 treatment significantly promotes the differentiation and bone matrix synthesis of mesenchymal stem cells, potentially through the activation of related signaling pathways, thereby enhancing bone formation. In contrast, the expression levels of the genes in the Ti, PTL, HA, and HA/HBPL groups were relatively stable. Therefore, the HA/HBPL3 group may have a stronger potential in promoting bone generation (<xref ref-type="fig" rid="F8">Figure&#x00A0;8a</xref>). The protein expression levels of COL I, OPN, OCN, and RUNX2 were also detected using WB technology in different treatment groups. The results showed that the HA/HBPL3 group exhibited significant upregulation in all target proteins, particularly COL I and OCN, whose expression levels were significantly higher than those in other groups. Additionally, OPN and RUNX2 proteins in the HA/HBPL3 group also showed increases, indicating that this group of treatment conditions exhibited the strongest effects in promoting the synthesis of related bone proteins. This suggests that the HA/HBPL3 group may enhance the synthesis of bone proteins through certain signaling pathways or molecular mechanisms, thereby promoting the differentiation and maturation of mesenchymal stem cells (<xref ref-type="fig" rid="F8">Figures&#x00A0;8b,c</xref>).</p>
<fig id="F8" position="float"><label>Figure 8</label>
<caption><p><bold>(a)</bold> expression of osteogenic-related genes. <bold>(b)</bold> Expression of osteogenic-related proteins. <bold>(c)</bold> Quantitative analysis of osteogenic-related protein expression. <bold>(d)</bold> H&#x0026;E staining of hard tissue sections from ectopic implantation. &#x002A;<italic>P</italic>&#x2009;&#x003C;&#x2009;0.05; &#x002A;&#x002A;&#x002A;<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="froh-06-1615280-g008.tif"><alt-text content-type="machine-generated">a. Bar graphs showing relative expression of OPN, OCN, RUNX2, and Col I mRNA normalized to GAPDH across different treatments: Ti, PTL, HA, HA/HB, and HA/HB3. b. Western blot image displaying protein levels of Col I, OCN, OPN, RUNX2, and GAPDH for the same treatments. c. Bar graphs representing densitometric analysis of the western blot data for OPN, OCN, RUNX2, and Col I against GAPDH. d. Histological images comparing bone tissue at 4 weeks and 8 weeks for Ti and HA/HB3 groups.</alt-text>
</graphic>
</fig>
<p>In addition, to comprehensively evaluate the bone-forming ability and biocompatibility of HA/HBPL3, we implanted the modified titanium plates into the back of mice to observe whether HA/HBPL3 could influence tissue healing or promote the formation of anomalous bone tissue under the complex physiological conditions of the body. The results showed that at 4 weeks, fibrous tissue surrounding the HA/HBPL3-modified titanium plates appeared, indicating that HA/HBPL3 could not induce anomalous bone formation without bone scaffold materials or natural bone structures. The wounds of the mice healed well, and no obvious inflammatory cells were observed under the microscope, suggesting that the modified coating had good biocompatibility (<xref ref-type="fig" rid="F8">Figure&#x00A0;8d</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>Surface modification techniques, which effectively endow substrate materials with novel functional properties without altering their inherent structural integrity, have garnered significant attention in materials science. To date, a spectrum of physicochemical methodologies has been extensively applied in surface engineering, including physical adsorption (<xref ref-type="bibr" rid="B16">16</xref>), plasma treatment (<xref ref-type="bibr" rid="B17">17</xref>), chemical vapor deposition (CVD) (<xref ref-type="bibr" rid="B18">18</xref>), and self-assembled monolayers (SAMs) (<xref ref-type="bibr" rid="B19">19</xref>). These advanced strategies have established pivotal roles across biomedical applications, ranging from implant biocompatibility enhancement to targeted drug delivery systems, underscoring their transformative potential in modern medical technologies.</p>
<p>In this study, we constructed a multilayered drug delivery system using negatively charged HA and positively charged HBPL, achieving direct drug release via a sacrificial template strategy. HA, a natural polysaccharide, exhibits non-toxicity, film-forming capability, biodegradability, and excellent biocompatibility (<xref ref-type="bibr" rid="B20">20</xref>). HBPL, characterized by its non-ordered, highly branched architecture and abundant terminal amino groups, combines structural motifs of both linear poly-L-lysine (PLL) and <italic>&#x03B5;</italic>-polylysine (<italic>&#x03B5;</italic>-PL). Recent studies have demonstrated that HBPL-modified titanium surfaces exhibit enhanced osseointegration, broad-spectrum antibacterial efficacy, and anti-inflammatory properties, positioning it as a multifunctional platform for advanced implant applications (<xref ref-type="bibr" rid="B21">21</xref>). Leveraging the electrostatic attraction between polyanionic HA and polycationic HBPL, the two components were alternately deposited on titanium surfaces to form polyelectrolyte complex films. Through three cycles of electrostatic adsorption, we successfully fabricated an antimicrobial polyelectrolyte coating with a trilayer &#x201C;sandwich-like&#x201D; architecture [(HA/HBPL)<sub>3</sub>]. By adjusting the number of adsorption cycles and initial polyelectrolyte concentrations, the drug release kinetics can be precisely modulated to achieve sustained release profiles. This multilayered structural design enables enhanced drug-loading capacity, combinatorial therapeutic options, and prolonged pharmacological activity duration.</p>
<p>The self-assembled polyelectrolyte films demonstrated structural integrity and stability while preserving their native morphology. Elemental composition analysis of the polyelectrolyte coatings confirmed successful layer deposition through the emergence of characteristic elements and concomitant depletion of substrate-specific signatures from preceding layers. Furthermore, enhanced surface hydrophilicity&#x2014;a critical factor promoting implant osseointegration&#x2014;was achieved post-self-assembly, as evidenced by water contact angle assays in this study (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). These findings collectively validate the feasibility of constructing polyelectrolyte multilayers via the LbL technique on PTL-modified titanium substrates, establishing a viable and effective strategy for developing functionalized implant surfaces with tailored physicochemical properties.</p>
<p>In this study, the HA/HBPL coating demonstrated significant antibacterial efficacy against oral pathogenic bacteria <italic>Streptococcus gordonii</italic> and <italic>S. sanguinis</italic>, providing a novel strategy to address bacterial infections and biofilm formation in oral biomaterials (<xref ref-type="bibr" rid="B24">24</xref>). Bacterial infections pose a critical challenge in dental implants and restorative materials, particularly due to biofilm development, which not only shields bacteria from antimicrobial agents but also fosters antibiotic resistance and chronic inflammation, ultimately compromising the long-term stability of implants (<xref ref-type="bibr" rid="B25">25</xref>). Consequently, the development of antimicrobial materials capable of inhibiting biofilm formation represents a pivotal research focus in the field of oral biomaterials.</p>
<p>Compared to conventional metal ion-based antibacterial approaches (<xref ref-type="bibr" rid="B26">26</xref>), the HA/HBPL coating not only demonstrates superior antimicrobial efficacy but also ensures biosafety and biodegradability in clinical applications due to its structural homology with biological matrices. This effectively circumvents potential cytotoxic effects associated with metal ion leaching. Confocal laser scanning microscopy (CLSM) analysis of live/dead stained bacteria revealed extensive red fluorescence across HA/HBPL-coated surfaces, indicating catastrophic membrane integrity loss and cytolysis in bacterial populations. In stark contrast, Ti and PTL substrates exhibited predominantly viable bacteria (green fluorescence), confirming the exceptional antibacterial superiority of the HA/HBPL coating. Antimicrobial peptides (AMPs) typically exert bactericidal effects by binding to bacterial cell membranes, altering membrane permeability, and ultimately inducing membrane disruption through lysis (<xref ref-type="bibr" rid="B27">27</xref>). Scanning electron microscopy (SEM) observations further corroborated this mechanism, revealing significant morphological deformations in bacteria adherent to HA/HBPL-coated surfaces, including membrane rupture and structural collapse. These findings demonstrate that the HA/HBPL coating likely compromises bacterial membrane integrity as its primary antimicrobial mode of action.</p>
<p>Although this study selected <italic>S. gordonii</italic> and <italic>S. sanguinis</italic>&#x2014;two pioneer species in dental plaque formation&#x2014;for experimental validation, the complexity of the oral microbiome far exceeds interactions between these two bacterial species. Future investigations should incorporate additional representative oral pathogens such as <italic>Porphyromonas gingivalis</italic> (<xref ref-type="bibr" rid="B28">28</xref>), <italic>Fusobacterium nucleatum</italic> (<xref ref-type="bibr" rid="B29">29</xref>), and even infection-associated <italic>Staphylococcus aureus</italic> to evaluate the broad-spectrum antimicrobial efficacy of the HA/HBPL coating across a comprehensive oral microbial consortium, thereby validating its clinical applicability. Furthermore, while the HA/HBPL coating demonstrated promising short-term antibacterial performance, its long-term stability and durability under physiological conditions require systematic evaluation through accelerated aging tests and simulated oral environment models.</p>
<p>Furthermore, this study systematically evaluated the effects of HA/HBPL<sub>3</sub> on osteogenic differentiation, proliferation, and bone formation through multiple experimental approaches. The results demonstrated that HA/HBPL<sub>3</sub> significantly enhanced osteoblast differentiation and matrix mineralization by upregulating osteogenesis-related RNA and protein expression levels, including COL1A1, OPN, OCN, and RUNX2, while concurrently increasing alkaline phosphatase (ALP) activity and promoting cell proliferation without observable cytotoxicity. Alizarin Red S staining, cytoskeletal fluorescence imaging, and protein adsorption assays further corroborated its capacity to facilitate mineralization and strengthen cell-matrix interactions.</p>
<p>In clinical applications, the HA/HBPL<sub>3</sub> composite coating holds significant promise for addressing bone defects complicated by comorbidities and enhancing dental implant osseointegration (<xref ref-type="bibr" rid="B30">30</xref>). By promoting the osteogenic function of osteoblasts, this coating can effectively augment cell-material interactions and provide innovative solutions for implant surface engineering. Furthermore, HA/HBPL<sub>3</sub> offers a novel therapeutic modality in oral implantation, facilitating the restoration of physiological function and anatomical structure while accelerating healing processes and improving long-term outcomes, thereby enhancing patients&#x0027; quality of life (<xref ref-type="bibr" rid="B31">31</xref>).With growing clinical demands, HA/HBPL<sub>3</sub> is poised to serve as a critical adjunct to conventional bone grafting biomaterials, particularly in scenarios with limited donor bone availability, offering patients a safe and effective alternative (<xref ref-type="bibr" rid="B32">32</xref>). Traditional bone grafting techniques face challenges including donor site morbidity and surgical risks. As a biodegradable material, HA/HBPL<sub>3</sub> addresses these limitations by eliminating concerns over wear particle-induced foreign body reactions and reducing dependence on technique-sensitive procedures.Future research directions will focus on elucidating HA/HBPL<sub>3</sub>&#x0027;s capacity to regulate cell signaling pathways and bone metabolism-related gene expression, thereby modulating bone formation processes. This mechanistic exploration will further establish its potential as a next-generation bioactive interface for bone regeneration applications.</p>
<p>As a dual-functional coating exhibiting both antimicrobial activity and osteoinductive potential, HA/HBPL<sub>3</sub> demonstrated favorable biocompatibility. However, clinical translation necessitates comprehensive validation through long-term efficacy studies, <italic>in vivo</italic> animal trials, and synergistic integration with complementary therapeutic strategies.</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusion</title>
<p>This study developed a dual-functional implant surface coating with combined antibacterial and osteogenic-enhancing properties. The coating was constructed through LbL self-assembly of biomolecules driven by electrostatic interactions, which optimized the physicochemical characteristics of the implant surface. The engineered coating not only exhibited robust antimicrobial efficacy and excellent biocompatibility but also significantly promoted bone regeneration. This innovative strategy provides a novel approach for clinical surface modification of dental implants and offers promising solutions for both preventing and managing peri-implantitis.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The animal study was approved by Animal Ethics Committee of Tianjin Fifth Central Hospital. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions"><title>Author contributions</title>
<p>ZL: Funding acquisition, Writing &#x2013; original draft, Visualization, Conceptualization. XZ: Writing &#x2013; review &#x0026; editing, Data curation, Methodology, Investigation. HY: Formal analysis, Writing &#x2013; original draft, Methodology. SZ: Project administration, Supervision, Writing &#x2013; review &#x0026; editing. HL: Writing &#x2013; original draft, Resources.</p>
</sec>
<sec id="s9" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the Tianjin Municipality Health Science and Technology Project (Grant No: TJWJ2023MS052).</p>
</sec>
<sec id="s10" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neoh</surname><given-names>KG</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>ET</given-names></name></person-group>. <article-title>Balancing osteoblast functions and bacterial adhesion on functionalized titanium surfaces</article-title>. <source>Biomaterials</source>. (<year>2012</year>) <volume>33</volume>(<issue>10</issue>):<fpage>2813</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.01.018</pub-id><pub-id pub-id-type="pmid">22257725</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>SB</given-names></name><name><surname>Pinkney</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>AF</given-names></name><name><surname>Tande</surname><given-names>AJ</given-names></name></person-group>. <article-title>Periprosthetic joint infection: current clinical challenges</article-title>. <source>Clin Infect Dis</source>. (<year>2023</year>) <volume>77</volume>(<issue>7</issue>):<fpage>e34</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciad360</pub-id><pub-id pub-id-type="pmid">37434369</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Busscher</surname><given-names>HJ</given-names></name><name><surname>van der Mei</surname><given-names>HC</given-names></name><name><surname>Subbiahdoss</surname><given-names>G</given-names></name><name><surname>Jutte</surname><given-names>PC</given-names></name><name><surname>van den Dungen</surname><given-names>JJAM</given-names></name><name><surname>Zaat</surname><given-names>SAJ</given-names></name><etal/></person-group> <article-title>Biomaterial-associated infection: locating the finish line in the race for the surface</article-title>. <source>Sci Transl Med</source>. (<year>2012</year>) <volume>4</volume>(<issue>153</issue>):<fpage>153rv10</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3004528</pub-id><pub-id pub-id-type="pmid">23019658</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smeets</surname><given-names>R</given-names></name><name><surname>Henningsen</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>O</given-names></name><name><surname>Heiland</surname><given-names>M</given-names></name><name><surname>Hamm&#x00E4;cher</surname><given-names>C</given-names></name><name><surname>Stein</surname><given-names>JM</given-names></name></person-group>. <article-title>Definition, etiology, prevention and treatment of peri-implantitis&#x2013;a review</article-title>. <source>Head Face Med</source>. (<year>2014</year>) <volume>10</volume>:<fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/1746-160X-10-34</pub-id><pub-id pub-id-type="pmid">25185675</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Chu</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Instant adhesion of amyloid-like nanofilms with wet surfaces</article-title>. <source>ACS Cent Sci</source>. (<year>2022</year>) <volume>8</volume>(<issue>6</issue>):<fpage>705</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.2c00151</pub-id><pub-id pub-id-type="pmid">35756378</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Muhammad</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Biopolymer coating for particle surface engineering and their biomedical applications</article-title>. <source>Mater Today Bio</source>. (<year>2022</year>) <volume>16</volume>:<fpage>100407</fpage>. <pub-id pub-id-type="doi">10.1016/j.mtbio.2022.100407</pub-id><pub-id pub-id-type="pmid">36090610</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group> <article-title>One-step assembly of a biomimetic biopolymer coating for particle surface engineering</article-title>. <source>Adv Mater</source>. (<year>2018</year>) <volume>30</volume>(<issue>38</issue>):<fpage>e1802851</fpage>. <pub-id pub-id-type="doi">10.1002/adma.201802851</pub-id><pub-id pub-id-type="pmid">30079540</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Lyu</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Silk acid as an implantable biomaterial for tissue regeneration</article-title>. <source>Adv Healthc Mater</source>. (<year>2023</year>) <volume>12</volume>(<issue>28</issue>):<fpage>e2301439</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202301439</pub-id><pub-id pub-id-type="pmid">37647626</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Amyloid-like protein aggregates: a new class of bioinspired materials merging an interfacial anchor with antifouling</article-title>. <source>Adv Mater</source>. (<year>2020</year>) <volume>32</volume>(<issue>23</issue>):<fpage>e2000128</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202000128</pub-id><pub-id pub-id-type="pmid">32346929</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RC</given-names></name><name><surname>Riollano</surname><given-names>M</given-names></name><name><surname>Leung</surname><given-names>A</given-names></name><name><surname>Hammond</surname><given-names>PT</given-names></name></person-group>. <article-title>Layer-by-layer platform technology for small-molecule delivery</article-title>. <source>Angew Chem Int Ed Engl</source>. (<year>2009</year>) <volume>48</volume>(<issue>47</issue>):<fpage>8974</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200902782</pub-id><pub-id pub-id-type="pmid">19847838</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Shiba</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Multifunctional biomaterial coating based on bio-inspired polyphosphate and lysozyme supramolecular nanofilm</article-title>. <source>Biomacromolecules</source>. (<year>2018</year>) <volume>19</volume>(<issue>6</issue>):<fpage>1979</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.8b00002</pub-id><pub-id pub-id-type="pmid">29432677</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Covalent grafting of hyperbranched poly-L-lysine on Ti-based implants achieves dual functions of antibacteria and promoted osteointegration <italic>in vivo</italic></article-title>. <source>Biomaterials</source>. (<year>2021</year>) <volume>269</volume>:<fpage>120534</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120534</pub-id><pub-id pub-id-type="pmid">33243425</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedrinha</surname><given-names>VF</given-names></name><name><surname>Cuellar</surname><given-names>MRC</given-names></name><name><surname>De Barros</surname><given-names>MC</given-names></name><name><surname>Titato</surname><given-names>PCG</given-names></name><name><surname>Shahbazi</surname><given-names>MA</given-names></name><name><surname>Sharma</surname><given-names>PK</given-names></name><etal/></person-group> <article-title>The vehicles of calcium hydroxide pastes interfere with antimicrobial effect, biofilm polysaccharidic matrix, and Pastes&#x2019; physicochemical properties</article-title>. <source>Biomedicines</source>. (<year>2022</year>) <volume>10</volume>(<issue>12</issue>):<fpage>3123</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines10123123</pub-id><pub-id pub-id-type="pmid">36551879</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JW</given-names></name><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Owen</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Haapasalo</surname><given-names>M</given-names></name><name><surname>Wiebe</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Scanning electron microscopic analysis of adherent bacterial biofilms associated with peri-implantitis</article-title>. <source>Clin Exp Dent Res</source>. (<year>2023</year>) <volume>9</volume>(<issue>4</issue>):<fpage>586</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/cre2.741</pub-id><pub-id pub-id-type="pmid">37157917</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pintatum</surname><given-names>A</given-names></name><name><surname>Maneerat</surname><given-names>W</given-names></name><name><surname>Logie</surname><given-names>E</given-names></name><name><surname>Tuenter</surname><given-names>E</given-names></name><name><surname>Sakavitsi</surname><given-names>ME</given-names></name><name><surname>Pieters</surname><given-names>L</given-names></name><etal/></person-group> <article-title><italic>In vitro</italic> anti-inflammatory, anti-oxidant, and cytotoxic activities of four <italic>Curcuma</italic> Species and the isolation of compounds from <italic>Curcuma aromatica</italic> rhizome</article-title>. <source>Biomolecules</source>. (<year>2020</year>) <volume>10</volume>(<issue>5</issue>):<fpage>799</fpage>. <pub-id pub-id-type="doi">10.3390/biom10050799</pub-id><pub-id pub-id-type="pmid">32455782</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filpponen</surname><given-names>I</given-names></name><name><surname>Kontturi</surname><given-names>E</given-names></name><name><surname>Nummelin</surname><given-names>S</given-names></name><name><surname>Rosilo</surname><given-names>H</given-names></name><name><surname>Kolehmainen</surname><given-names>E</given-names></name><name><surname>Ikkala</surname><given-names>O</given-names></name><etal/></person-group> <article-title>Generic method for modular surface modification of cellulosic materials in aqueous medium by sequential &#x201C;click&#x201D; reaction and adsorption</article-title>. <source>Biomacromolecules</source>. (<year>2012</year>) <volume>13</volume>(<issue>3</issue>):<fpage>736</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1021/bm201661k</pub-id><pub-id pub-id-type="pmid">22257019</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makary</surname><given-names>C</given-names></name><name><surname>Menhall</surname><given-names>A</given-names></name><name><surname>Lahoud</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>KR</given-names></name><name><surname>Park</surname><given-names>KB</given-names></name><name><surname>Razukevicius</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Bone-to-implant contact in implants with plasma-treated nanostructured calcium-incorporated surface (XPEEDActive) compared to non-plasma-treated implants (XPEED): a human histologic study at 4 weeks</article-title>. <source>Materials (Basel)</source>. (<year>2024</year>) <volume>17</volume>(<issue>10</issue>):<fpage>2331</fpage>. <pub-id pub-id-type="doi">10.3390/ma17102331</pub-id><pub-id pub-id-type="pmid">38793397</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>GR</given-names></name><name><surname>Lee</surname><given-names>HR</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Heo</surname><given-names>DN</given-names></name><etal/></person-group> <article-title>Simple and facile preparation of recombinant human bone morphogenetic protein-2 immobilized titanium implant via initiated chemical vapor deposition technique to promote osteogenesis for bone tissue engineering application</article-title>. <source>Mater Sci Eng C Mater Biol Appl</source>. (<year>2019</year>) <volume>100</volume>:<fpage>949</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2019.03.048</pub-id><pub-id pub-id-type="pmid">30948131</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>W-C</given-names></name><name><surname>Huang</surname><given-names>T-S</given-names></name><name><surname>Cho</surname><given-names>Y-C</given-names></name><name><surname>Huang</surname><given-names>Y-T</given-names></name><name><surname>Walinski</surname><given-names>CJ</given-names></name><name><surname>Chiang</surname><given-names>P-C</given-names></name><etal/></person-group> <article-title>The potential of a nanostructured titanium oxide layer with self-assembled monolayers for biomedical applications: surface properties and biomechanical behaviors</article-title>. <source>Appl Sci</source>. (<year>2020</year>) <volume>10</volume>(<issue>2</issue>):<fpage>590</fpage>. <pub-id pub-id-type="doi">10.3390/app10020590</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gra&#x00E7;a</surname><given-names>MFP</given-names></name><name><surname>Miguel</surname><given-names>SP</given-names></name><name><surname>Cabral</surname><given-names>CSD</given-names></name><name><surname>Correia</surname><given-names>IJ</given-names></name></person-group>. <article-title>Hyaluronic acid-based wound dressings: a review</article-title>. <source>Carbohydr Polym</source>. (<year>2020</year>) <volume>241</volume>:<fpage>116364</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2020.116364</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>Hyperbranched poly-l-lysine modified titanium surface with enhanced osseointegration, bacteriostasis, and anti-inflammatory properties for implant application: an experimental <italic>in vivo</italic> study</article-title>. <source>Clin Oral Implants Res</source>. (<year>2025</year>) <volume>36</volume>(<issue>1</issue>):<fpage>28</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1111/clr.14354</pub-id><pub-id pub-id-type="pmid">39262294</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>L</given-names></name><name><surname>Ghezzi</surname><given-names>B</given-names></name><name><surname>Bianchi</surname><given-names>MG</given-names></name><name><surname>Toffoli</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>F</given-names></name><name><surname>Bussolati</surname><given-names>O</given-names></name><etal/></person-group> <article-title>Titanium dental implants hydrophilicity promotes preferential serum fibronectin over albumin competitive adsorption modulating early cell response</article-title>. <source>Mater Sci Eng C Mater Biol Appl</source>. (<year>2020</year>) <volume>117</volume>:<fpage>111307</fpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2020.111307</pub-id><pub-id pub-id-type="pmid">32919668</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>J</given-names></name><name><surname>Sartori</surname><given-names>E</given-names></name><name><surname>Rizzante</surname><given-names>F</given-names></name><name><surname>Siqueira</surname><given-names>R</given-names></name><name><surname>Mendon&#x00E7;a</surname><given-names>D</given-names></name><name><surname>de Magalh&#x00E3;es</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Analysis <italic>in vivo</italic> of bone modulation in hydrophilic and hydrophobic Titanium implant surfaces</article-title>. <source>Int J Oral Maxillofac Implants</source>. (<year>2021</year>) <volume>36</volume>(<issue>4</issue>):<fpage>650</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.11607/jomi.8748</pub-id><pub-id pub-id-type="pmid">34411204</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>RC</given-names></name><name><surname>Nagay</surname><given-names>BE</given-names></name><name><surname>Bertolini</surname><given-names>M</given-names></name><name><surname>Costa-Oliveira</surname><given-names>BE</given-names></name><name><surname>Sampaio</surname><given-names>AA</given-names></name><name><surname>Retamal-Valdes</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Fitting pieces into the puzzle: the impact of titanium-based dental implant surface modifications on bacterial accumulation and polymicrobial infections</article-title>. <source>Adv Colloid Interface Sci</source>. (<year>2021</year>) <volume>298</volume>:<fpage>102551</fpage>. <pub-id pub-id-type="doi">10.1016/j.cis.2021.102551</pub-id><pub-id pub-id-type="pmid">34757285</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Thian</surname><given-names>ES</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name></person-group>. <article-title>Surface design for antibacterial materials: from fundamentals to advanced strategies</article-title>. <source>Adv Sci (Weinh)</source>. (<year>2021</year>) <volume>8</volume>(<issue>19</issue>):<fpage>e2100368</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202100368</pub-id><pub-id pub-id-type="pmid">34351704</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perdikaki</surname><given-names>A</given-names></name><name><surname>Galeou</surname><given-names>A</given-names></name><name><surname>Pilatos</surname><given-names>G</given-names></name><name><surname>Prombona</surname><given-names>A</given-names></name><name><surname>Karanikolos</surname><given-names>GN</given-names></name></person-group>. <article-title>Ion-based metal/graphene antibacterial agents comprising mono-ionic and bi-ionic silver and copper species</article-title>. <source>Langmuir</source>. (<year>2018</year>) <volume>34</volume>(<issue>37</issue>):<fpage>11156</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.8b01880</pub-id><pub-id pub-id-type="pmid">30145895</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elangwe</surname><given-names>CN</given-names></name><name><surname>Morozkina</surname><given-names>SN</given-names></name><name><surname>Olekhnovich</surname><given-names>RO</given-names></name><name><surname>Polyakova</surname><given-names>VO</given-names></name><name><surname>Krasichkov</surname><given-names>A</given-names></name><name><surname>Yablonskiy</surname><given-names>PK</given-names></name><etal/></person-group> <article-title>Pullulan-based hydrogels in wound healing and skin tissue engineering applications: a review</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>(<issue>5</issue>):<fpage>4962</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24054962</pub-id><pub-id pub-id-type="pmid">36902394</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y-Q</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Erythrocyte-mimicking nanovesicle targeting Porphyromonas gingivalis for periodontitis</article-title>. <source>ACS Nano</source>. (<year>2024</year>) <volume>18</volume>(<issue>32</issue>):<fpage>21077</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.4c02316</pub-id><pub-id pub-id-type="pmid">39088785</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alon-Maimon</surname><given-names>T</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name><name><surname>Bachrach</surname><given-names>G</given-names></name></person-group>. <article-title>Fusobacterium nucleatum and cancer</article-title>. <source>Periodontol 2000</source>. (<year>2022</year>) <volume>89</volume>(<issue>1</issue>):<fpage>166</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12426</pub-id><pub-id pub-id-type="pmid">35244982</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>Q</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Hyperbranched polylysine exhibits a collaborative enhancement of the antibiotic capacity to kill gram-negative pathogens</article-title>. <source>Antibiotics (Basel)</source>. (<year>2024</year>) <volume>13</volume>(<issue>3</issue>):<fpage>217</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics13030217</pub-id><pub-id pub-id-type="pmid">38534651</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Qu</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Cationic polysaccharide conjugates as antibiotic adjuvants resensitize multidrug-resistant Bacteria and prevent resistance</article-title>. <source>Adv Mater</source>. (<year>2022</year>) <volume>34</volume>(<issue>41</issue>):<fpage>e2204065</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202204065</pub-id><pub-id pub-id-type="pmid">35962720</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elhelow</surname><given-names>KM</given-names></name><name><surname>Al-Thobaiti</surname><given-names>YE</given-names></name><name><surname>Gomawi</surname><given-names>AA</given-names></name></person-group>. <article-title>The prosthetic rehabilitation of a patient with a lateral postsurgical defect using a 2-piece magnet-retained facial prosthesis: a clinical report</article-title>. <source>J Prosthet Dent</source>. (<year>2018</year>) <volume>119</volume>(<issue>5</issue>):<fpage>848</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.prosdent.2017.05.021</pub-id><pub-id pub-id-type="pmid">28918299</pub-id></citation></ref></ref-list>
</back>
</article>